SCHEMBL4284136

SCHEMBL4284136

COc1ccc(Cc2ccc(C=O)cc2OCc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
TDP1 Q9NUW8 1/20 0.59
ABCB1 P08183 2/20 0.52
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAOB P27338 2/20 0.50
MAOA P21397 1/20 0.50
LTA4H P09960 1/20 0.49
MAPT P10636 2/20 0.48
HTT P42858 1/20 0.48
PDCD1 Q15116 1/20 0.47
CD274 Q9NZQ7 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TACR2 P21452 1/20 0.46
TTR P02766 1/20 0.46
APP P05067 1/20 0.46
GSK3B P49841 1/20 0.46
BACE1 P56817 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6819289 0.89 MAOA (0.56) NPC1RAB9AALDH1A1SMN1; SMN2MAOB
SCHEMBL2463491 0.88 NPC1 (0.63) NPC1RAB9ATDP1ABCB1ALDH1A1
SCHEMBL4281014 0.88 ABCB1 (0.52) NPC1RAB9ATDP1ABCB1MAOB
SCHEMBL4285680 0.87 TACR2 (0.51) NPC1RAB9ATDP1ALDH1A1SMN1; SMN2
SCHEMBL4287005 0.87 ABCB1 (0.49) NPC1RAB9ATDP1ABCB1MAOB
SCHEMBL4287000 0.87 ABCB1 (0.49) NPC1RAB9ATDP1ABCB1MAOB
SCHEMBL4290933 0.87 ABCB1 (0.49) NPC1RAB9ATDP1ABCB1MAOB
SCHEMBL27563776 0.84 MAOB (0.57) TDP1ABCB1ALDH1A1MAOBLTA4H
SCHEMBL14540441 0.83 ABCB1 (0.67) NPC1RAB9ATDP1ABCB1ALDH1A1
SCHEMBL8983142 0.83 NPC1 (0.65) NPC1RAB9ATDP1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 NPC1 153/4885RAB9A 1308/4885TDP1 4772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.